These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 29715421)
1. [Advances of Function of Prussian Blue Nano-materials in Cancer Diagnosis and Therapy]. Jin X; Qu H; Zhu C; Jing L; Yu T Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2016 Dec; 33(6):1209-13. PubMed ID: 29715421 [TBL] [Abstract][Full Text] [Related]
2. PEGylated Prussian blue nanocubes as a theranostic agent for simultaneous cancer imaging and photothermal therapy. Cheng L; Gong H; Zhu W; Liu J; Wang X; Liu G; Liu Z Biomaterials; 2014 Dec; 35(37):9844-9852. PubMed ID: 25239041 [TBL] [Abstract][Full Text] [Related]
3. Nanosized Prussian blue and its analogs for bioimaging and cancer theranostics. Wang P; Sun S; Bai G; Zhang R; Liang F; Zhang Y Acta Biomater; 2024 Mar; 176():77-98. PubMed ID: 38176673 [TBL] [Abstract][Full Text] [Related]
4. A long-term stability study of Prussian blue: A quality assessment of water content and cesium binding. Mohammad A; Yang Y; Khan MA; Faustino PJ J Pharm Biomed Anal; 2015 Jan; 103():85-90. PubMed ID: 25462125 [TBL] [Abstract][Full Text] [Related]
5. Soluble or insoluble prussian blue for radiocesium and thallium poisoning? Thompson DF; Callen ED Ann Pharmacother; 2004 Sep; 38(9):1509-14. PubMed ID: 15252192 [TBL] [Abstract][Full Text] [Related]
6. Prussian blue coated gold nanoparticles for simultaneous photoacoustic/CT bimodal imaging and photothermal ablation of cancer. Jing L; Liang X; Deng Z; Feng S; Li X; Huang M; Li C; Dai Z Biomaterials; 2014 Jul; 35(22):5814-21. PubMed ID: 24746962 [TBL] [Abstract][Full Text] [Related]
7. Recent progress in Prussian blue films: Methods used to control regular nanostructures for electrochemical biosensing applications. Chu Z; Liu Y; Jin W Biosens Bioelectron; 2017 Oct; 96():17-25. PubMed ID: 28458130 [TBL] [Abstract][Full Text] [Related]
8. Prussian blue nanoparticles and their analogues for application to cancer theranostics. Patra CR Nanomedicine (Lond); 2016 Mar; 11(6):569-72. PubMed ID: 26911239 [No Abstract] [Full Text] [Related]
9. Quantitative determination of cesium binding to ferric hexacyanoferrate: Prussian blue. Faustino PJ; Yang Y; Progar JJ; Brownell CR; Sadrieh N; May JC; Leutzinger E; Place DA; Duffy EP; Houn F; Loewke SA; Mecozzi VJ; Ellison CD; Khan MA; Hussain AS; Lyon RC J Pharm Biomed Anal; 2008 May; 47(1):114-25. PubMed ID: 18242038 [TBL] [Abstract][Full Text] [Related]
10. D-penicillamine and prussian blue as antidotes against thallium intoxication in rats. Rìos C; Monroy-Noyola A Toxicology; 1992 Aug; 74(1):69-76. PubMed ID: 1514189 [TBL] [Abstract][Full Text] [Related]
11. Long-term stability study of Prussian blue - a quality assessment of water content and thallium binding. Mohammad A; Faustino PJ; Khan MA; Yang Y Int J Pharm; 2014 Dec; 477(1-2):122-7. PubMed ID: 25311178 [TBL] [Abstract][Full Text] [Related]
12. Combined D-penicillamine and prussian blue as antidotal treatment against thallotoxicosis in rats: evaluation of cerebellar lesions. Barroso-Moguel R; Villeda-Hernández J; Méndez-Armenta M; Ríos C; Monroy-Noyola A Toxicology; 1994 Mar; 89(1):15-24. PubMed ID: 8178320 [TBL] [Abstract][Full Text] [Related]
13. Long-term stability study of Prussian blue-A quality assessment of water content and cyanide release. Mohammad A; Yang Y; Khan MA; Faustino PJ Clin Toxicol (Phila); 2015 Feb; 53(2):102-7. PubMed ID: 25608705 [TBL] [Abstract][Full Text] [Related]
14. Determination of total antioxidant capacity of Cynara Scolymus L. (globe artichoke) by using novel nanoparticle-based ferricyanide/Prussian blue assay. Kanmaz N; Uzer A; Hizal J; Apak R Talanta; 2020 Aug; 216():120960. PubMed ID: 32456941 [TBL] [Abstract][Full Text] [Related]
15. Additive effect of DL-penicillamine plus Prussian blue for the antidotal treatment of thallotoxicosis in rats. Montes S; Pérez-Barrón G; Rubio-Osornio M; Ríos C; Diaz-Ruíz A; Altagracia-Martínez M; Monroy-Noyola A Environ Toxicol Pharmacol; 2011 Nov; 32(3):349-55. PubMed ID: 22004953 [TBL] [Abstract][Full Text] [Related]
16. Quantitative determination of thallium binding to ferric hexacyanoferrate: Prussian blue. Yang Y; Faustino PJ; Progar JJ; Brownell CR; Sadrieh N; May JC; Leutzinger E; Place DA; Duffy EP; Yu LX; Khan MA; Lyon RC Int J Pharm; 2008 Apr; 353(1-2):187-94. PubMed ID: 18226478 [TBL] [Abstract][Full Text] [Related]
17. Characterization and electrocatalytic properties of Prussian blue electrochemically deposited on nano-Au/PAMAM dendrimer-modified gold electrode. Li NB; Park JH; Park K; Kwon SJ; Shin H; Kwak J Biosens Bioelectron; 2008 May; 23(10):1519-26. PubMed ID: 18289843 [TBL] [Abstract][Full Text] [Related]
18. Prussian blue type nanoparticles for biomedical applications. Long J; Guari Y; Guérin C; Larionova J Dalton Trans; 2016 Nov; 45(44):17581-17587. PubMed ID: 27278267 [TBL] [Abstract][Full Text] [Related]
19. Prussian blue nanoparticles: Synthesis, surface modification, and application in cancer treatment. Gautam M; Poudel K; Yong CS; Kim JO Int J Pharm; 2018 Oct; 549(1-2):31-49. PubMed ID: 30053487 [TBL] [Abstract][Full Text] [Related]
20. Efficacy of Prussian blue on 137Cs decorporation therapy. Melo DR; Lipsztein JL; Leggett R; Bertelli L; Guilmette R Health Phys; 2014 May; 106(5):592-7. PubMed ID: 24670908 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]